Volume : 11, Issue : 11, November – 2024
Title:
FORMULATION AND ESTIMATION OF ATOMOXETINE HCL BUCCAL DRUG DELIVERY SYSTEM
Authors :
Ms. Geeta M. Khonde*, Dr. Kamble H. V, Mr. Deshpande M.J., Mr. Sugriv R. Ghodake
Abstract :
The study focused on developing and evaluating mucoadhesive buccal films for enhanced drug delivery using a solvent casting method. Among the formulations (F1-F9), F2 emerged as the optimized batch, demonstrating superior quality attributes. F2 exhibited excellent transparency, minimal weight variation (43.56%), low moisture content (3.2%), optimal thickness (0.02 mm), high folding endurance (110), and a pH of 6.8. It also achieved the highest drug content (98.14%) and tensile strength (25.63 gm/mm²), ensuring stability, robustness, and effective drug delivery. The ex-vivo diffusion study confirmed that F2 achieved 95.56% drug permeation at 10 minutes, surpassing other formulations. Stability studies over three months revealed no significant changes in thickness, drug content, or drug release. The results demonstrate that formulation F2 is a promising candidate for mucoadhesive buccal drug delivery, offering consistent quality, efficient drug release, and stability over time.
Keywords: Mucoadhesive buccal films, drug delivery, solvent casting, folding endurance, drug content, ex-vivo diffusion, stability studies.
Cite This Article:
Please cite this article in press Geeta M. Khonde et al., Formulation And Estimation Of Atomoxetine Hcl Buccal Drug Delivery System..,Indo Am. J. P. Sci, 2024; 11 (11).
Number of Downloads : 10
References:
1. Allen LV, Popovich NG, Ansel HC. Ansel’s Pharmaceutical Dosage Forms and Drug Delivery Systems. 10th ed. Philadelphia: Wolters Kluwer; 2018.
2. ICH Harmonised Tripartite Guideline. Stability Testing of New Drug Substances and Products Q1A (R2). International Conference on Harmonisation; 2003.
3. Aulton ME, Taylor KMG. Aulton’s Pharmaceutics: The Design and Manufacture of Medicines. 5th ed. Elsevier; 2018.
4. Jain NK. Advances in Controlled and Novel Drug Delivery. 1st ed. CBS Publishers & Distributors; 2017.
5. Phaechamud T, Choncheewa C. Mucoadhesive buccal films: Drug delivery and physicochemical considerations. J Pharm Innov. 2022;17(1):45-58.
6. Carin MA, Chaiyasit K, Srisatjaluk R, et al. Effect of plasticizers on the mechanical and mucoadhesive properties of buccal films. Int J Pharm Sci Res. 2021;12(5):2334-9.
7. Mohapatra A, Parikh RK, Gohel MC, et al. Fabrication and evaluation of buccal films of atenolol. Asian J Pharm. 2020;14(4):182-8.
8. United States Pharmacopeia (USP). General Chapters: <601> In vitro and Ex vivo Drug Release Studies. Rockville: United States Pharmacopeia; 2020.
9. Salehi B, Mishra AP, Shukla I, et al. Recent advances in mucoadhesive drug delivery systems: Formulation, evaluation, and applications. J Control Release. 2020;320:325-45.
10. Rowe RC, Sheskey PJ, Quinn ME. Handbook of Pharmaceutical Excipients. 7th ed. Pharmaceutical Press; 2012.
11. Perioli L, Ambrogi V, Angelici F, et al. Development of mucoadhesive patches for buccal administration of ibuprofen. Drug Dev Ind Pharm. 2004;30(1):49-57.
12. Cilurzo F, Cupone IE, Minghetti P, et al. Diclofenac fast-dissolving film: Suppression of bitterness by a taste-sensing system. Drug Dev Ind Pharm. 2011;37(3):252-9.
13. Boateng JS, Matthews KH, Stevens HN, Eccleston GM. Wound healing dressings and drug delivery systems: A review. J Pharm Sci. 2008;97(8):2892-923.
14. ICH Harmonised Tripartite Guideline. Validation of Analytical Procedures: Text and Methodology Q2(R1). International Conference on Harmonisation; 2005.
15. Nafee NA, Boraie NA, Ismail FA, Mortada LM. Design and characterization of mucoadhesive buccal patches containing cetylpyridinium chloride. Acta Pharm. 2003;53(3):199-212.
16. Nafee NA, Ismail FA, Boraie NA, Mortada LM. Mucoadhesive delivery systems. I. Evaluation of mucoadhesive polymers for buccal tablet formulation. Drug Dev Ind Pharm. 2004;30(9):985-93.
17. Peh KK, Wong CF. Polymeric films as vehicle for buccal delivery: Swelling, mechanical, and bioadhesive properties. J Pharm Pharm Sci. 1999;2(2):53-61.
18. Siepmann J, Peppas NA. Modeling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC). Adv Drug Deliv Rev. 2001;48(2-3):139-57.
19. Agarwal V, Mishra B. Design, development and biopharmaceutical properties of buccoadhesive carvedilol tablets. Acta Pharm. 2006;56(4):483-90.
20. Nafee NA, Boraie NA, Ismail FA, Mortada LM. Design and optimization of mucoadhesive buccal patches containing cetylpyridinium chloride. Drug Dev Ind Pharm. 2003;53(2):199-212.
21. Salehi S, Boddohi S. New formulation and approach for mucoadhesive buccal film of rizatriptan benzoate. Progress in biomaterials. 2017 Dec; 6:175-87.
22. Rokade PS, Patil PM. Development and validation of analytical method for estimation of 5-Fluorouracil in bulk and marketed formulation by UV- spectrophotometer. J Pharm Sci Rev Res. 2017;42:8-11.
23. Kshirsagar T, Jaiswal N, Chavan G, Zambre K, Ramkrushna S, Dinesh D. Formulation & evaluation of fast dissolving oral film. World J. Pharm. Res. 2021 Jul;10(9):503-61.
24. Mokhtar M, Sammour OA, Hammad MA, Megrab NA. Effect of some formulation parameters on flurbiprofen encapsulation and release rates of niosomes prepared from proniosomes. International journal of pharmaceutics. 2008 Sep 1;361(1-2):104-11.
25. Wade A, Weller PJ. Benzalkonium Chloride. Benzethonium Chloride,”” Cetrimide,” in: Handbook of Pharmaceutical Excipients, American Pharmaceutical Association, Washington, DC. 1994:27- 31.
26. Paolino D, Cosco D, Muzzalupo R, Trapasso E, Picci N, Fresta M. Innovative bola-surfactant niosomes as topical delivery systems of 5-fluorouracil for the treatment of skin cancer. International journal of Pharmaceutics. 2008 Apr 2;353(1-2):233-42.
27. Samy M, Abd El-Alim SH, Amin A, Ayoub MM. Formulation, characterization and in vitro release study of 5- fluorouracil loaded chitosan nanoparticles. International journal of biological macromolecules. 2020 Aug 1;156:783- 91.
28. Londhe VY, Umalkar KB. Formulation development and evaluation of fast dissolving film of telmisartan. Indian Journal of Pharmaceutical Sciences. 2012 Mar;74(2):122.
29. Pathan A, Gupta MK, Jain NK, Dubey A, Agrawal A. Formulation and evaluation of fast dissolving oral film of
30. promethazine hydrochloride using different surfactant. J. Innov. Pharm. Bio. Sci. 2016;3(1):74-84.
31. Chavan DU, Marques SM, Bhide PJ, Kumar L, Shirodkar RK. Rapidly dissolving felodipine nanoparticle strips-formulation using design of experiment and characterisation. Journal of Drug Delivery Science and Technology. 2020 Dec 1;60:102053.
32. Nalluri BN, Sravani B, Anusha VS, Sribramhini R, Maheswari KM. Development and evaluation of mouth dissolving films of sumatriptan succinate for better therapeutic efficacy. Journal of applied pharmaceutical science. 2013 Aug 30;3(8):161-6.
33. Bharti K, Mittal P, Mishra B. Formulation and characterization of fast dissolving oral films containing buspirone hydrochloride nanoparticles using design of experiment. Journal of Drug Delivery Science and Technology. 2019 Feb 1;49:420-32.
34. Dixit RP, Puthli SP. Oral strip technology: Overview and future potential. Journal of controlled release. 2009 Oct 15; 139(2):94-107.
35. Chougule PC. Design and evaluation of formulated mouth dissolving film of domperidone and study the effect of concentration of polymers on drug release. Asian Journal of Pharmaceutics (AJP). 2017;11(04).
36. Ramzan M, Gourion-Arsiquaud S, Hussain A, Gulati JS, Zhang Q, Trehan S, Puri V, Michniak-Kohn B, Kaur IP. In vitro release, ex vivo penetration, and in vivo dermatokinetics of ketoconazole-loaded solid lipid nanoparticles for topical delivery. Drug Delivery and Translational Research. 2022 Jul 1:1-25.
37. Patel DM, Patel DJ, Darji PJ. Formulation and evaluation of fast dissolving film of cetirizine & Dextromethorphan. Int Jr Ph Sci &Nanotech. 2016;9(3):3305-11.